Finance

Beta
Lists
APGE:NASDAQ
Apogee Therapeutics Inc
$86.92
-4.38%
(-3.98) 1D
$86.90
-0.02% (-0.020)
After hours
Closed: Jun 5, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for APGE...
Open
$90.00
High
$91.90
Low
$85.75
Mkt. cap
6.55B
Avg. vol.
846.73K
Volume
1.31M
52-wk high
$95.32
52-wk low
$34.34
EPS
-$4.33
Shares outstanding
61.90M
No. of employees
261
Open
$90.00
High
$91.90
Low
$85.75
Mkt. cap
6.55B
Avg. vol.
846.73K
Volume
1.31M
52-wk high
$95.32
52-wk low
$34.34
EPS
-$4.33
Shares outstanding
61.90M
No. of employees
261
Analyst outlook
Analyst Ratings
Based on 16 analysts giving stock ratings to APGE in the past 3 months
Strong Buy
Buy
13
Hold
3
Sell
0
12 month forecast
Based on 16 Wall Street analysts offering 12 month price targets for APGE in the last 3 months.
Highest
Current $86.92
$160.00 (+84.08%)
Average
$118.00 (+35.76%)
Lowest
$81.00 (-6.81%)
News stories
From sources across the web
About Apogee Therapeutics Inc
CEO-
Employees261
Founded2022
HeadquartersWaltham, Massachusetts, United States
SectorBiotechnology
Websiteapogeetherapeutics.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
55.70M
54.18M
58.44M
60.82M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
17.46M
17.10M
19.61M
21.95M
Operating expense
73.16M
71.28M
78.06M
82.77M
Total operating expenses
73.16M
71.28M
78.06M
82.77M
Operating income
-73.16M
-71.28M
-78.06M
-82.77M
Other non operating income
-
-
-
-
EBT including unusual items
-66.02M
-64.96M
-69.32M
-74.03M
EBT excluding unusual items
-66.02M
-64.96M
-69.32M
-74.03M
Income tax expense
72.00K
61.00K
62.00K
79.00K
Effective tax rate
-0.11%
-0.09%
-0.09%
-0.11%
Other operating expenses
-
-
-
-
Net income
-66.10M
-65.02M
-69.39M
-74.11M
Net profit margin
-
-
-
-
Earnings per share
-1.13
-1.11
-1.03
-1.06
Interest and investment income
7.14M
6.32M
8.73M
8.74M
Interest expense
-
-
-
-
Net interest expenses
7.14M
6.32M
8.73M
8.74M
Depreciation and amortization charges
-
-
-
-
EBITDA
-72.77M
-70.87M
-77.65M
-82.36M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer